The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression

被引:319
|
作者
Umansky, Viktor [1 ,2 ]
Blattner, Carolin [1 ,2 ]
Gebhardt, Christoffer [1 ,2 ]
Utikal, Jochen [1 ,2 ]
机构
[1] German Canc Res Ctr, Skin Canc Unit, D-69120 Heidelberg, Germany
[2] Ruprecht Karl Univ Heidelberg, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, D-68167 Mannheim, Germany
关键词
myeloid-derived suppressor cells; myelopoiesis; tumor microenvironment; immunosuppression; therapeutic targeting; TRANS-RETINOIC ACID; INDUCED IMMUNE SUPPRESSION; TUMOR-BEARING HOSTS; REGULATORY T-CELLS; CHRONIC INFLAMMATION; GROWTH-FACTOR; NITRIC-OXIDE; ANTITUMOR IMMUNITY; INTERFERON-GAMMA; PROGENITOR CELLS;
D O I
10.3390/vaccines4040036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immunosuppressive tumor microenvironment represents not only one of the key factors stimulating tumor progression but also a strong obstacle for efficient tumor immunotherapy. Immunosuppression was found to be associated with chronic inflammatory mediators including cytokines, chemokines and growth factors produced by cancer and stroma cells. Long-term intensive production of these factors induces the formation of myeloid-derived suppressor cells (MDSCs) representing one of the most important players mediating immunosuppression. Moreover, MDSCs could not only inhibit anti-tumor immune reactions but also directly stimulate tumor growth and metastasis. Therefore, understanding the mechanisms of their generation, expansion, recruitment and activation is required for the development of novel strategies for tumor immunotherapy.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Profiling myeloid-derived suppressor cells during mouse prostate cancer progression
    Nozawa, Masahiro
    Develasco, Marco A.
    Kura, Yurie
    Sakai, Kazuko
    Adomi, Syogo
    Nishimoto, Mituhisa
    Minami, Takafumi
    Mori, Yasunori
    Fujita, Kazutoshi
    Yoshimura, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER SCIENCE, 2024, 115 : 803 - 803
  • [42] Myeloid-derived suppressor cells in cancer and cancer therapy
    Samantha A. Lasser
    Feyza G. Ozbay Kurt
    Ihor Arkhypov
    Jochen Utikal
    Viktor Umansky
    Nature Reviews Clinical Oncology, 2024, 21 : 147 - 164
  • [43] Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency
    Salminen, Antero
    Kaarniranta, Kai
    Kauppinen, Anu
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2019, 76 (10) : 1901 - 1918
  • [44] Myeloid-derived suppressor cells in cancer and cancer therapy
    Lasser, Samantha A.
    Kurt, Feyza G. Ozbay
    Arkhypov, Ihor
    Utikal, Jochen
    Umansky, Viktor
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (02) : 147 - 164
  • [45] Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression
    Yin, Kai
    Xia, Xueli
    Rui, Ke
    Wang, Tingting
    Wang, Shengjun
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [46] Myeloid-derived suppressor cells (MDSC) are increased and correlated with immune suppression and chronic inflammation in patients with cancer
    Gonda, Kenji
    Shibata, Masahiko
    Shimura, Tatsuo
    Nakamura, Izumi
    Ohki, Shinji
    Ohtake, Tohru
    Suzuki, Shinichi
    Ohto, Hitoshi
    Takenoshita, Seiichi
    CANCER RESEARCH, 2012, 72
  • [47] The role of myeloid-derived suppressor cells in lung cancer and targeted immunotherapies
    Sheida, Fateme
    Razi, Sepideh
    Keshavarz-Fathi, Mahsa
    Rezaei, Nima
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (01) : 65 - 81
  • [48] Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells
    Moses, Katrin
    Brandau, Sven
    SEMINARS IN IMMUNOLOGY, 2016, 28 (02) : 187 - 196
  • [49] Myeloid-derived suppressor cells
    Nagaraj, Srinivas
    Gabrilovich, Dmitry I.
    IMMUNE-MEDIATED DISEASES: FROM THEORY TO THERAPY, 2007, 601 : 213 - 223
  • [50] Myeloid-Derived Suppressor Cells
    Gabrilovich, Dmitry I.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (01) : 3 - 8